EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...

It is noteworthy that patients with mild TBI often report visual issues despite normal results of visual acuity measurements ...

More than 300 patients have been randomized in the SOL-1 Phase 3 trial for OTX-TKI (AXPAXLI, axitinib intravitreal implant).

Researchers described the presence of multiple bilateral serous retinal detachments (SRDs) found in 3 women after they used ...

The authors searched PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports ...

The phase 2b/3 trial of izokibep in non-infectious, non-anterior uveitis did not meet the primary endpoint of a statistically significant improvement in time to treatment failure versus placebo as ...

XLRP is a severe, progressive inherited retinal disease that leads to blindness, typically by middle age, and currently has no approved treatments. It primarily affects young males, with an estimated ...

To educate the public—including parents, caregivers, and allied health professionals—Prevent Blindness is offering free educational resources, including fact sheets, social media graphics, web pages, ...

A program from National Health Service (NHS) England will bring optical coherence tomography (OCT) scans “closer to home” for thousands of patients. As part of an effort to improve outcomes for ...